Search
-
Leading pharmaceutical brands demonstrating leadership
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
-
Pharma Sales Need to Know About Covid-19 & HCP Practices
Hear results from the first-wave of our new regular Covid-19 HCP Surveillance Research of 300+ HCPs across seven specialties.
-
Medical Devices & Diagnostics Pulse Survey: Diabetes
Check out the latest results from our Medical Devices & Diagnostics Pulse Survey, focusing on Diabetes – with results benchmarked to 2018.
-
DTx Pricing & Reimbursement
Hear experts share a review of manufacturer experiences with payer assessments of DTx for pricing and reimbursement purposes.
-
Improving In-Store Conversion Through Behavioral Science
Discover the competitive importance of combining traditional research techniques with the science of how shoppers make decisions to dramatically improve in-store results.
-
The Future of Healthcare Diagnostics
Download the latest results from our Medical Devices & Diagnostics Pulse Survey, focusing on the exciting future of Healthcare Diagnostics.
-
Medical Devices & Diagnostics Pulse Survey: Radiology
Check out the latest survey results from our Medical Devices & Diagnostics Pulse, focusing on Radiology: learn the latest trends in 2019, benchmarked to 2017.